Top compounds associated with response to CARD17


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA bid1870 gCSI pan-cancer AAC 0.018 0.7
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA Bortezomib gCSI pan-cancer AAC 0.019 0.8
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.012 0.8
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.017 0.8
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA austocystin d CTRPv2 pan-cancer AAC 0.012 0.8
Download CSV